Advisory Committee on the Medical Uses of Isotopes: Call for Nominations, 51649 [E8-20477]

Download as PDF sroberts on PROD1PC77 with NOTICES Federal Register / Vol. 73, No. 172 / Thursday, September 4, 2008 / Notices October 23, 2008, and shortly thereafter will issue a public version of the report with any confidential business information deleted. Additional information concerning the articles and the proposed modifications can be obtained by accessing the electronic version of this investigation and the USTR request letter at the Commission Internet site (https://www.usitc.gov). The current USAFTA rules of origin applicable to U.S. imports can be found in general note 28 of the 2008 HTS (see General Notes link at https:// www.usitc.gov/tata/hts/bychapter/ index.htm). The HTS subheading affected is 5510.90. All other subheadings covered by the current rules of origin would experience no change. Written Submissions: No public hearing is planned. However, interested parties are invited to submit written statements concerning this investigation. All written submissions should be addressed to the Secretary, and should be received not later than 5:15 p.m., September 17, 2008. All written submissions must conform to the provisions of section 201.8 of the Commission’s Rules of Practice and Procedure (19 CFR 201.8). Section 201.8 requires that a signed original (or a copy so designated) and fourteen (14) copies of each document be filed. In the event that confidential treatment of a document is requested, at least four (4) additional copies must be filed, in which the confidential information must be deleted (see the following paragraph for further information regarding confidential business information). The Commission’s rules authorize filing submissions with the Secretary by facsimile or electronic means only to the extent permitted by section 201.8 of the rules (see Handbook for Electronic Filing Procedures, https:// www.usitc.gov/secretary/ fed_reg_notices/rules/documents/ handbook_on_electronic_filing.pdf). Persons with questions regarding electronic filing should contact the Secretary (202–205–2000). Any submissions that contain confidential business information must also conform to the requirements of section 201.6 of the Commission’s Rules of Practice and Procedure (19 CFR 201.6). Section 201.6 of the rules requires that the cover of the document and the individual pages be clearly marked as to whether they are the confidential or non-confidential version, and that the confidential business information is clearly identified by means of brackets. All written submissions, except for confidential business information, will be made VerDate Aug<31>2005 18:46 Sep 03, 2008 Jkt 214001 available for inspection by interested parties. The Commission may include some or all of the confidential business information submitted in the course of this investigation in the report it sends to the USTR and the President. As requested by the USTR, the Commission will publish a public version of the report. However, in the public version, the Commission will not publish confidential business information in a manner that would reveal the operations of the firm supplying the information. Issued: August 28, 2008. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E8–20495 Filed 9–3–08; 8:45 am] BILLING CODE 7020–02–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Call for Nominations U.S. Nuclear Regulatory Commission. ACTION: Call for Nominations. AGENCY: SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising for nominations for three upcoming vacancies on NRC’s Advisory Committee on the Medical Uses of Isotopes (ACMUI): radiation oncologist with experience in gamma stereotactic radiosurgery, nuclear medicine physicist, and radiation safety officer. DATES: Nominations are due on or before November 3, 2008. Nomination Process: Submit an electronic copy of resume or curriculum vitae to Ms. Ashley Tull, ashley.tull@nrc.gov. Please ensure that resume or curriculum vitae includes the following information, if applicable: Education; certification; professional association membership and committee membership activities; duties and responsibilities in current and previous clinical, research, and/or academic position(s). FOR FURTHER INFORMATION CONTACT: Ms. Ashley Tull, U.S. Nuclear Regulatory Commission, Office of Federal and State Materials and Environmental Management Programs; (240) 888–7129; ashley.tull@nrc.gov. SUPPLEMENTARY INFORMATION: The ACMUI advises NRC on policy and technical issues that arise in the regulation of the medical use of byproduct material. Responsibilities include providing comments on changes to NRC rules, regulations, and guidance PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 51649 documents; evaluating certain nonroutine uses of byproduct material; providing technical assistance in licensing and inspections; and bringing key issues to the attention of NRC, for appropriate action. ACMUI members possess the medical and technical skills needed to address evolving issues. The current membership is comprised of the following professionals: (a) Nuclear medicine physician; (b) nuclear cardiologist; (c) nuclear medicine physicist; (d) therapy medical physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) patients’ rights advocate; (i) Food and Drug Administration representative; (j) Agreement State representative; and (k) health care administrator. NRC is inviting nominations for the nuclear medicine physicist, radiation oncologist, and radiation safety officer appointments to the ACMUI. The term of the individuals currently occupying these positions will end May 19, 2009, September 30, 2009 and September 30, 2009, respectively. Committee members currently serve a four-year term and may be considered for reappointment to an additional term. Nominees must be U.S. citizens and be able to devote approximately 160 hours per year to Committee business. Members who are not Federal employees are compensated for their service. In addition, members are reimbursed travel (including per-diem in lieu of subsistence) and are reimbursed secretarial and correspondence expenses. Full-time Federal employees are reimbursed travel expenses only. Security Background Check: The selected nominee will undergo a thorough security background check. Security paperwork may take the nominee several weeks to complete. Nominees will also be required to complete a financial disclosure statement to avoid conflicts of interest. Dated at Rockville, Maryland this 28th day of August 2008. For the U.S. Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. E8–20477 Filed 9–3–08; 8:45 am] BILLING CODE 7590–01–P E:\FR\FM\04SEN1.SGM 04SEN1

Agencies

[Federal Register Volume 73, Number 172 (Thursday, September 4, 2008)]
[Notices]
[Page 51649]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-20477]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for three upcoming vacancies on NRC's Advisory 
Committee on the Medical Uses of Isotopes (ACMUI): radiation oncologist 
with experience in gamma stereotactic radiosurgery, nuclear medicine 
physicist, and radiation safety officer.

DATES: Nominations are due on or before November 3, 2008.
    Nomination Process: Submit an electronic copy of resume or 
curriculum vitae to Ms. Ashley Tull, ashley.tull@nrc.gov. Please ensure 
that resume or curriculum vitae includes the following information, if 
applicable: Education; certification; professional association 
membership and committee membership activities; duties and 
responsibilities in current and previous clinical, research, and/or 
academic position(s).

FOR FURTHER INFORMATION CONTACT: Ms. Ashley Tull, U.S. Nuclear 
Regulatory Commission, Office of Federal and State Materials and 
Environmental Management Programs; (240) 888-7129; ashley.tull@nrc.gov.

SUPPLEMENTARY INFORMATION: The ACMUI advises NRC on policy and 
technical issues that arise in the regulation of the medical use of 
byproduct material. Responsibilities include providing comments on 
changes to NRC rules, regulations, and guidance documents; evaluating 
certain non-routine uses of byproduct material; providing technical 
assistance in licensing and inspections; and bringing key issues to the 
attention of NRC, for appropriate action.
    ACMUI members possess the medical and technical skills needed to 
address evolving issues. The current membership is comprised of the 
following professionals: (a) Nuclear medicine physician; (b) nuclear 
cardiologist; (c) nuclear medicine physicist; (d) therapy medical 
physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) 
two radiation oncologists; (h) patients' rights advocate; (i) Food and 
Drug Administration representative; (j) Agreement State representative; 
and (k) health care administrator.
    NRC is inviting nominations for the nuclear medicine physicist, 
radiation oncologist, and radiation safety officer appointments to the 
ACMUI. The term of the individuals currently occupying these positions 
will end May 19, 2009, September 30, 2009 and September 30, 2009, 
respectively. Committee members currently serve a four-year term and 
may be considered for reappointment to an additional term.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members who are not Federal 
employees are compensated for their service. In addition, members are 
reimbursed travel (including per-diem in lieu of subsistence) and are 
reimbursed secretarial and correspondence expenses. Full-time Federal 
employees are reimbursed travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland this 28th day of August 2008.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
 [FR Doc. E8-20477 Filed 9-3-08; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.